North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

May 2020 | 117 pages | ID: NAB193F78313EN
GMD Research

Abstracts

North America artificial intelligence (AI) in drug discovery market is expected to grow by 29.5% annually in the forecast period and reach $894.1 million by 2026 despite the COVID-19 impact.

Highlighted with 27 tables and 50 figures, this 117-page report “North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.
Based on offering, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Software
• Service

Based on technology, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technologies

Based on drug type, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Large-molecule Drugs
• Small-molecular Drugs

Based on therapeutic area, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Other Therapeutic Areas

Based on application, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Information & Data Analysis
• Drug Design
• Drug Evaluation
• Clinical Trials
• Other Applications

Based on end user, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America AI in drug discovery market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY OFFERING

3.1 Market Overview by Offering
3.2 Software
3.3 Service

4 SEGMENTATION OF NORTH AMERICA MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Deep Learning
4.3 Supervised Learning
4.4 Reinforcement Learning
4.5 Unsupervised Learning
4.6 Other Technologies

5 SEGMENTATION OF NORTH AMERICA MARKET BY DRUG TYPE

5.1 Market Overview by Drug Type
5.2 Large-molecule Drugs
5.3 Small-molecular Drugs

6 SEGMENTATION OF NORTH AMERICA MARKET BY THERAPEUTIC AREA

6.1 Market Overview by Therapeutic Area
6.2 Oncology
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Disease
6.5 Metabolic Diseases
6.6 Other Therapeutic Areas

7 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

7.1 Market Overview by Application
7.2 Information & Data Analysis
7.3 Drug Design
7.4 Drug Evaluation
7.5 Clinical Trials
7.6 Other Applications

8 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Contract Research Organizations

9 NORTH AMERICA MARKET 2019-2026 BY COUNTRY

9.1 Overview of North America Market
9.2 U.S.
9.3 Canada
9.4 Mexico

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.

11 INVESTING IN NORTH AMERICA MARKET: RISK ASSESSMENT AND MANAGEMENT

11.1 Risk Evaluation of North America Market
11.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of North America AI in Drug Discovery Market, 2019-2026
Table 2. Main Product Trends and Market Opportunities in North America AI in Drug Discovery Market
Table 3. North America AI in Drug Discovery Market by Offering, 2015-2026, $ mn
Table 4. North America AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 5. North America AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn
Table 6. North America AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 7. Selected Drug Development Pipelines Aided by AI
Table 8. North America AI in Drug Discovery Market by Application, 2015-2026, $ mn
Table 9. North America AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 10. North America AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 11. U.S. AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 12. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 13. U.S. AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 14. Canada AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 15. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 16. Canada AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 17. Mexico AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 18. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 19. Mexico AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 20. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies
Table 21. Atomwise, Inc.: Company Snapshot
Table 22. Atomwise, Inc.: Business Segmentation
Table 23. Atomwise, Inc.: Product Portfolio
Table 24. Atomwise, Inc.: Revenue, 2016-2018, $ mn
Table 25. Atomwise, Inc.: Recent Developments
Table 26. Risk Evaluation for Investing in North America Market, 2019-2026
Table 27. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 5. North America AI in Drug Discovery Market, 2019-2026, $ mn
Figure 6. Primary Drivers and Impact Factors of North America AI in Drug Discovery Market
Figure 7. Primary Restraints and Impact Factors of North America AI in Drug Discovery Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of North America AI in Drug Discovery Market
Figure 10. Breakdown of North America AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue
Figure 11. Contribution to North America 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%)
Figure 12. North America AI in Drug Discovery Market: Software, 2015-2026, $ mn
Figure 13. North America AI in Drug Discovery Market: Service, 2015-2026, $ mn
Figure 14. Breakdown of North America AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue
Figure 15. Contribution to North America 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%)
Figure 16. North America AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn
Figure 17. North America AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn
Figure 18. North America AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn
Figure 19. North America AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn
Figure 20. North America AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn
Figure 21. Breakdown of North America AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue
Figure 22. Contribution to North America 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%)
Figure 23. North America AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn
Figure 24. North America AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn
Figure 25. Breakdown of North America AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue
Figure 26. Contribution to North America 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%)
Figure 27. North America AI in Drug Discovery Market: Oncology, 2015-2026, $ mn
Figure 28. North America AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn
Figure 29. North America AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn
Figure 30. North America AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn
Figure 31. North America AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn
Figure 32. Breakdown of North America AI in Drug Discovery Market by Application, 2019-2026, % of Revenue
Figure 33. Contribution to North America 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 34. North America AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn
Figure 35. North America AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn
Figure 36. North America AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn
Figure 37. North America AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn
Figure 38. North America AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn
Figure 39. Breakdown of North America AI in Drug Discovery Market by End User, 2019-2026, % of Revenue
Figure 40. Contribution to North America 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 41. North America AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn
Figure 42. North America AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn
Figure 43. North America AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn
Figure 44. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 45. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 46. U.S. AI in Drug Discovery Market, 2015-2026, $ mn
Figure 47. Canada AI in Drug Discovery Market, 2015-2026, $ mn
Figure 48. AI in Drug Discovery Market in Mexico, 2015-2026, $ mn
Figure 49. Growth Stage of North America AI in Drug Discovery Industry over the Forecast Period
Figure 50. Share of Developments of Key Vendors by Strategy Type, 2015-2019